Immunoassay
Ligand binding assays developed, validated, and implemented to GxP across wide-ranging therapeutic modalities.
Services:
- Assay development, validation and sample analysis
- Supporting PK/TK studies
- De novo and kit-based biomarker assay implementation
- Target capture, anti-drug Ab capture, Ab Sandwich assays
Therapeutic Modalities:
- Monoclonal antibodies (mAbs)
- Antibody fragments (Fab, nanobody, domain Abs)
- Antibody drug conjugates (ADCs)
- Proteins
- Peptides
- Bispecifics
- Biosimilars
- AAVs, gene therapy
Technologies:
- ELISA (absorbance, luminescence, fluorescence)
- GyroLab xPand, xPlore™
- Quanterix (HDX Simoa)
- Electrochemiluminescence (MSD Sector Imager 6000, QuickPlex)
- Luminex (Magpix, Flexmap 3D)
- Flow cytometry (Beckman Coulter CytoFLEX)
- qPCR (QuantStudio™ 7) and Hybridization ELISA
- Luminex Flexmap 3D
- Protein Simple Ella
- Thermo Scientific NanoDrop
- Hamilton STAR Robotics
Reach out to us directly to learn more about Resolian’s Immunoassay services.
